Impressions from Boston by Björn Walse, CEO, SARomics Biostructures

I had the great pleasure to visit Boston the last two weeks of September. The reason for the trip was to participate in BioPharm America 2013 (#BPA13) and Discovery on Target 2013 (#DOTBoston13). This blog is about my impressions from the last of these meetings and from my stay in the area. 

After three intensive days packed with excellent talks about epigenetics readers, writers and erasers I am completely astonished at how fast this field is moving forward. For example, the lysine…

Read More